FILGRASTIM

FILGRASTIM was reported 37861 times

FILGRASTIM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 149 0.9739
1 THYMUS HYPOPLASIA 147 0.8448
2 HUMAN BOCAVIRUS INFECTION 124 0.6561
3 COMPUTERISED TOMOGRAM THORAX 39 0.6500
4 BLOOD STEM CELL HARVEST FAILURE 66 0.4459
5 CYSTITIS BACTERIAL 110 0.3254
6 NOROVIRUS TEST POSITIVE 94 0.2892
7 NEUROBLASTOMA RECURRENT 53 0.2611
8 MYCOBACTERIUM CHELONAE INFECTION 168 0.2273
9 DISSEMINATED ASPERGILLOSIS 104 0.2203
10 MENINGITIS TUBERCULOUS 116 0.2075
11 SECONDARY IMMUNODEFICIENCY 239 0.1967
12 ABSCESS BACTERIAL 71 0.1956
13 COLONY STIMULATING FACTOR THERAPY 32 0.1546
14 ENGRAFT FAILURE 44 0.1533
15 CORONA VIRUS INFECTION 59 0.1372
16 PSEUDOMONAL SEPSIS 236 0.1346
17 COMPUTERISED TOMOGRAM THORAX ABNORMAL 75 0.1092
18 BLOOD STEM CELL TRANSPLANT FAILURE 23 0.1070
19 PARAINFLUENZAE VIRUS INFECTION 162 0.1064
20 CYSTITIS VIRAL 36 0.0940
21 AORTITIS 64 0.0933
22 ENTEROBACTER INFECTION 151 0.0898
23 HUMAN HERPESVIRUS 6 INFECTION 167 0.0883
24 ACUTE MYELOID LEUKAEMIA RECURRENT 185 0.0861
25 ENGRAFTMENT SYNDROME 47 0.0795
26 VIRAEMIA 106 0.0765
27 NEUTROPENIC INFECTION 73 0.0763
28 DIFFUSE ALVEOLAR DAMAGE 82 0.0713
29 FEBRILE NEUTROPENIA 4533 0.0683
30 VIRAL HAEMORRHAGIC CYSTITIS 44 0.0618
31 CYTOMEGALOVIRUS VIRAEMIA 260 0.0584
32 NEUTROPENIC SEPSIS 414 0.0579
33 CYTOMEGALOVIRUS CHORIORETINITIS 113 0.0579
34 NEUTROPENIC COLITIS 117 0.0565
35 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 52 0.0562
36 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 52 0.0549
37 STAPHYLOCOCCAL BACTERAEMIA 230 0.0529
38 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 38 0.0529
39 ESCHERICHIA BACTERAEMIA 121 0.0514
40 FUSARIUM INFECTION 35 0.0500
41 PNEUMATOSIS INTESTINALIS 137 0.0480
42 BILIARY SEPSIS 22 0.0475
43 KLEBSIELLA BACTERAEMIA 45 0.0474
44 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 126 0.0455
45 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 64 0.0453
46 PSEUDOMONAL BACTERAEMIA 38 0.0445
47 STREPTOCOCCAL BACTERAEMIA 48 0.0441
48 CRYSTAL NEPHROPATHY 26 0.0439
49 B-CELL LYMPHOMA RECURRENT 23 0.0424
50 RHINOVIRUS INFECTION 165 0.0424
51 APLASIA 83 0.0423
52 CLOSTRIDIUM DIFFICILE COLITIS 445 0.0419
53 ACUTE GRAFT VERSUS HOST DISEASE 192 0.0419
54 KLEBSIELLA SEPSIS 47 0.0417
55 APLASTIC ANAEMIA 216 0.0413
56 SINUSITIS FUNGAL 33 0.0411
57 PLATELET TRANSFUSION 52 0.0404
58 BACILLUS INFECTION 25 0.0396
59 CAMPYLOBACTER GASTROENTERITIS 23 0.0388
60 BRONCHOPULMONARY ASPERGILLOSIS 298 0.0384
61 CYTOMEGALOVIRUS TEST POSITIVE 66 0.0370
62 CHRONIC GRAFT VERSUS HOST DISEASE 133 0.0368
63 GASTROENTERITIS NOROVIRUS 48 0.0361
64 ENTEROCOCCAL SEPSIS 29 0.0358
65 STREPTOCOCCAL SEPSIS 42 0.0354
66 CAPILLARY LEAK SYNDROME 70 0.0338
67 TONSILLAR DISORDER 37 0.0329
68 STEM CELL TRANSPLANT 82 0.0328
69 MUCOSAL INFLAMMATION 856 0.0327
70 MARROW HYPERPLASIA 22 0.0323
71 PNEUMONIA KLEBSIELLA 59 0.0321
72 DEVICE RELATED THROMBOSIS 31 0.0314
73 PERIPHERAL MOTOR NEUROPATHY 44 0.0314
74 CYSTITIS HAEMORRHAGIC 124 0.0307
75 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 79 0.0306
76 SPLENIC RUPTURE 50 0.0304
77 CANDIDA SEPSIS 27 0.0301
78 VENOOCCLUSIVE LIVER DISEASE 147 0.0297
79 ACUTE MYELOID LEUKAEMIA 463 0.0297
80 VENOOCCLUSIVE DISEASE 74 0.0295
81 BACTERIAL INFECTION 549 0.0294
82 ENTERITIS 188 0.0293
83 SYSTEMIC CANDIDA 73 0.0290
84 OESOPHAGEAL CANDIDIASIS 113 0.0283
85 ALVEOLITIS 40 0.0283
86 TRANSPLANT FAILURE 69 0.0281
87 NEUTROPHIL COUNT ABNORMAL 79 0.0279
88 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 65 0.0279
89 CYTOKINE RELEASE SYNDROME 558 0.0278
90 ESCHERICHIA SEPSIS 80 0.0276
91 FEBRILE BONE MARROW APLASIA 116 0.0273
92 GRAFT VERSUS HOST DISEASE 196 0.0272
93 ASPERGILLOSIS 35 0.0268
94 LEUKAEMIA RECURRENT 45 0.0266
95 ENTEROCOCCAL BACTERAEMIA 28 0.0264
96 HEMIANOPIA 26 0.0262
97 NEUTROPENIA 3559 0.0261
98 HYPOALBUMINAEMIA 203 0.0261
99 BLOOD CULTURE POSITIVE 78 0.0260
100 PERIPHERAL SENSORY NEUROPATHY 150 0.0256
101 PNEUMONIA FUNGAL 101 0.0256
102 CYTOMEGALOVIRUS INFECTION REACTIVATION 113 0.0256
103 OSTEOLYSIS 52 0.0254
104 GRAFT VERSUS HOST DISEASE IN SKIN 56 0.0254
105 VENOUS THROMBOSIS 99 0.0252
106 ENTEROCOCCAL INFECTION 121 0.0250
107 BK VIRUS INFECTION 83 0.0246
108 PANCYTOPENIA 1366 0.0244
109 GENE MUTATION 48 0.0242
110 PLASMA CELL MYELOMA RECURRENT 76 0.0234
111 MYELODYSPLASTIC SYNDROME 337 0.0233
112 BACTERIAL SEPSIS 75 0.0230
113 ASPERGILLUS INFECTION 151 0.0230
114 ACUTE LYMPHOCYTIC LEUKAEMIA 65 0.0229
115 HYPOGONADISM 23 0.0227
116 ADENOVIRUS INFECTION 66 0.0227
117 LYMPHADENITIS 55 0.0227
118 HERPES SIMPLEX 147 0.0226
119 FOLATE DEFICIENCY 26 0.0225
120 SYSTEMIC MYCOSIS 26 0.0223
121 PHARYNGEAL INFLAMMATION 27 0.0222
122 NEUTROPHIL COUNT DECREASED 902 0.0221
123 BONE MARROW FAILURE 443 0.0218
124 OSTEOSCLEROSIS 34 0.0216
125 HAEMATOTOXICITY 205 0.0216
126 CYTOPENIA 258 0.0211
127 FUNGAEMIA 33 0.0210
128 ATELECTASIS 200 0.0207
129 STAPHYLOCOCCAL SEPSIS 102 0.0206
130 EPIDIDYMITIS 24 0.0206
131 PNEUMONIA CYTOMEGALOVIRAL 40 0.0206
132 BACTERAEMIA 242 0.0204
133 SKIN TOXICITY 115 0.0203
134 CENTRAL NERVOUS SYSTEM LYMPHOMA 28 0.0203
135 LYMPHOPENIA 287 0.0203
136 WHITE BLOOD CELL COUNT ABNORMAL 129 0.0202
137 SUBCLAVIAN VEIN THROMBOSIS 23 0.0202
138 TUMOUR LYSIS SYNDROME 173 0.0196
139 FEBRILE INFECTION 23 0.0195
140 BLOOD BILIRUBIN ABNORMAL 25 0.0195
141 KLEBSIELLA INFECTION 98 0.0194
142 CYTOMEGALOVIRUS INFECTION 319 0.0192
143 SOFT TISSUE INFECTION 35 0.0191
144 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 33 0.0187
145 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 93 0.0186
146 BONE PAIN 1093 0.0186
147 CARDIAC VENTRICULAR THROMBOSIS 24 0.0186
148 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 39 0.0183
149 EXCESSIVE EYE BLINKING 27 0.0183
150 THROMBOCYTOPENIA 2022 0.0181
151 INTRACARDIAC THROMBUS 55 0.0179
152 BONE MARROW DISORDER 54 0.0179
153 PNEUMONIA PSEUDOMONAL 27 0.0176
154 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 104 0.0175
155 SPLENOMEGALY 205 0.0175
156 GASTROINTESTINAL TOXICITY 84 0.0175
157 HYPOPHOSPHATAEMIA 129 0.0174
158 ONYCHOLYSIS 27 0.0173
159 HYPERPHOSPHATAEMIA 37 0.0172
160 ESCHERICHIA INFECTION 141 0.0171
161 URETERIC OBSTRUCTION 23 0.0168
162 PARONYCHIA 74 0.0168
163 PSEUDOMONAS INFECTION 141 0.0164
164 HYPOGAMMAGLOBULINAEMIA 108 0.0164
165 CLOSTRIDIUM TEST POSITIVE 36 0.0163
166 PERIODONTITIS 35 0.0161
167 THROMBOTIC MICROANGIOPATHY 156 0.0160
168 SEPTIC SHOCK 693 0.0159
169 BONE MARROW TRANSPLANT 30 0.0158
170 SYSTEMIC INFECTION 26 0.0157
171 INTENSIVE CARE 22 0.0155
172 PNEUMOCYSTIS JIROVECI PNEUMONIA 34 0.0152
173 PSEUDOMEMBRANOUS COLITIS 34 0.0152
174 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 114 0.0152
175 LYMPH NODE PAIN 28 0.0150
176 LEUKOPENIA 752 0.0150
177 WHITE BLOOD CELL DISORDER 40 0.0149
178 NASAL DISORDER 39 0.0147
179 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 32 0.0145
180 LUNG INFILTRATION 128 0.0145
181 MANTLE CELL LYMPHOMA 22 0.0144
182 HEPATOSPLENOMEGALY 37 0.0144
183 AGRANULOCYTOSIS 266 0.0143
184 LUNG CONSOLIDATION 40 0.0143
185 STREPTOCOCCAL INFECTION 79 0.0142
186 PULMONARY HAEMORRHAGE 111 0.0142
187 RESPIRATORY TRACT INFECTION VIRAL 33 0.0142
188 THERAPY PARTIAL RESPONDER 218 0.0140
189 LYMPHOCYTOSIS 30 0.0139
190 MULTIPLE ORGAN DYSFUNCTION SYNDROME 394 0.0139
191 ABDOMINAL MASS 37 0.0138
192 SPLENIC INFARCTION 24 0.0137
193 CHRONIC SINUSITIS 51 0.0136
194 SEPSIS 1511 0.0135
195 HISTIOCYTOSIS HAEMATOPHAGIC 40 0.0135
196 VASCULAR DEVICE INFECTION 61 0.0134
197 ACUTE RESPIRATORY DISTRESS SYNDROME 236 0.0133
198 WHITE BLOOD CELL COUNT DECREASED 1439 0.0133
199 DIFFUSE LARGE B-CELL LYMPHOMA 101 0.0131
200 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 108 0.0131
201 CYTOMEGALOVIRUS COLITIS 30 0.0130
202 NEOPLASM RECURRENCE 44 0.0130
203 LEUKOCYTOSIS 234 0.0129
204 PLASMACYTOMA 24 0.0129
205 HYPOMAGNESAEMIA 179 0.0128
206 HYPOKALAEMIA 587 0.0127
207 MULTIPLE MYELOMA 59 0.0126
208 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 48 0.0126
209 FIBROSIS 38 0.0123
210 INTERCEPTED PRODUCT ADMINISTRATION ERROR 94 0.0122
211 BONE LESION 44 0.0122
212 MULTI-ORGAN FAILURE 208 0.0120
213 LYMPHADENOPATHY MEDIASTINAL 23 0.0120
214 APLASIA PURE RED CELL 41 0.0119
215 BLOOD MAGNESIUM DECREASED 102 0.0118
216 HYPOXIA 416 0.0118
217 LIVEDO RETICULARIS 24 0.0115
218 STAPHYLOCOCCUS TEST POSITIVE 24 0.0114
219 DERMATITIS EXFOLIATIVE GENERALISED 39 0.0112
220 BLOOD LACTATE DEHYDROGENASE INCREASED 176 0.0111
221 VARICELLA ZOSTER VIRUS INFECTION 23 0.0111
222 PLASMA CELL MYELOMA 431 0.0110
223 NEUTROPHIL COUNT INCREASED 112 0.0109
224 NEUROTOXICITY 191 0.0109
225 HAEMOLYTIC URAEMIC SYNDROME 25 0.0108
226 HEART RATE ABNORMAL 60 0.0107
227 ENTEROCOLITIS 62 0.0107
228 EPSTEIN-BARR VIRUS INFECTION 67 0.0107
229 POLYNEUROPATHY 128 0.0107
230 URINARY TRACT INFECTION BACTERIAL 27 0.0107
231 OTITIS MEDIA 35 0.0106
232 PLATELET COUNT ABNORMAL 64 0.0106
233 ENCEPHALITIS 73 0.0105
234 GRANULOCYTOPENIA 60 0.0105
235 FUNGAL INFECTION 347 0.0104
236 CHRONIC LYMPHOCYTIC LEUKAEMIA 49 0.0103
237 THROMBOPHLEBITIS 36 0.0103
238 CANDIDIASIS 41 0.0102
239 PLATELET COUNT DECREASED 1087 0.0102
240 VIRAL INFECTION 339 0.0102
241 NEPHROPATHY TOXIC 114 0.0101
242 EXPOSED BONE IN JAW 22 0.0101
243 HYPERBILIRUBINAEMIA 105 0.0101
244 AORTIC ARTERIOSCLEROSIS 26 0.0101
245 SECOND PRIMARY MALIGNANCY 84 0.0101
246 B-CELL LYMPHOMA 34 0.0100
247 CANDIDA INFECTION 169 0.0100
248 CLOSTRIDIUM DIFFICILE INFECTION 218 0.0100
249 ORGANISING PNEUMONIA 49 0.0099
250 DEVICE RELATED INFECTION 151 0.0098
251 ODYNOPHAGIA 58 0.0097
252 BLOOD IMMUNOGLOBULIN G DECREASED 24 0.0097
253 ORAL CANDIDIASIS 127 0.0096
254 ELECTROLYTE IMBALANCE 112 0.0096
255 METASTASES TO LYMPH NODES 65 0.0096
256 MUCORMYCOSIS 25 0.0096
257 BLOOD DISORDER 77 0.0096
258 ANAEMIA 1832 0.0096
259 PLEURITIC PAIN 26 0.0094
260 GLOMERULONEPHRITIS 23 0.0094
261 AUTOIMMUNE HAEMOLYTIC ANAEMIA 32 0.0093
262 ORAL HERPES 182 0.0093
263 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 47 0.0092
264 ORAL FUNGAL INFECTION 25 0.0091
265 HYDRONEPHROSIS 68 0.0091
266 CARDIOTOXICITY 81 0.0091
267 SINUS TACHYCARDIA 127 0.0089
268 PULMONARY TOXICITY 63 0.0089
269 OESOPHAGITIS 97 0.0089
270 BREAST CANCER RECURRENT 28 0.0089
271 NON-CARDIAC CHEST PAIN 28 0.0088
272 TOXIC EPIDERMAL NECROLYSIS 134 0.0088
273 PLEURAL EFFUSION 536 0.0088
274 COVID-19 PNEUMONIA 104 0.0088
275 ACUTE RESPIRATORY FAILURE 168 0.0087
276 TRANSFUSION 91 0.0087
277 PNEUMOCYSTIS JIROVECII PNEUMONIA 87 0.0087
278 SERUM SICKNESS 24 0.0086
279 FLUID INTAKE REDUCED 43 0.0086
280 CELLULITIS 432 0.0086
281 PNEUMONITIS 233 0.0085
282 CACHEXIA 44 0.0085
283 STOMATITIS 518 0.0085
284 DISSEMINATED INTRAVASCULAR COAGULATION 120 0.0085
285 VARICOSE VEIN 44 0.0085
286 RASH MACULO-PAPULAR 189 0.0085
287 PYREXIA 2929 0.0085
288 EJECTION FRACTION DECREASED 131 0.0084
289 DEVICE OPERATIONAL ISSUE 36 0.0084
290 COLITIS 316 0.0083
291 BLOOD CREATININE DECREASED 26 0.0083
292 HYPOCALCAEMIA 156 0.0082
293 PETECHIAE 85 0.0081
294 LYMPHADENOPATHY 288 0.0081
295 RESPIRATORY FAILURE 584 0.0080
296 ERYSIPELAS 40 0.0080
297 GASTROINTESTINAL NECROSIS 23 0.0079
298 HYPERCALCAEMIA 97 0.0078
299 DISEASE PROGRESSION 925 0.0078
300 HYPERURICAEMIA 32 0.0078
301 SERUM FERRITIN INCREASED 41 0.0078
302 METASTASES TO SPINE 26 0.0077
303 HEPATOTOXICITY 171 0.0077
304 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 255 0.0075
305 NEUROPATHY PERIPHERAL 708 0.0074
306 PROTEIN TOTAL DECREASED 28 0.0074
307 TRICUSPID VALVE INCOMPETENCE 59 0.0074
308 METASTASES TO LIVER 130 0.0074
309 INFECTION 1067 0.0074
310 ATYPICAL PNEUMONIA 22 0.0073
311 FIBRIN D DIMER INCREASED 26 0.0073
312 BRONCHOPNEUMONIA 25 0.0073
313 PNEUMONIA BACTERIAL 67 0.0073
314 TRANSPLANT REJECTION 58 0.0072
315 ORGAN FAILURE 29 0.0072
316 HAEMOGLOBIN ABNORMAL 46 0.0071
317 RASH PUSTULAR 52 0.0071
318 VASCULITIS 83 0.0071
319 STAPHYLOCOCCAL INFECTION 235 0.0071
320 ERYTHEMA NODOSUM 25 0.0071
321 BLOOD BILIRUBIN INCREASED 191 0.0071
322 ESCHERICHIA URINARY TRACT INFECTION 30 0.0071
323 NO THERAPEUTIC RESPONSE 86 0.0070
324 WHITE BLOOD CELL COUNT INCREASED 269 0.0070
325 RED BLOOD CELL COUNT DECREASED 200 0.0070
326 EMBOLISM 58 0.0070
327 LYMPHOCYTE COUNT DECREASED 123 0.0070
328 CORONAVIRUS INFECTION 46 0.0069
329 HAEMATOCRIT DECREASED 136 0.0069
330 NEUTROPHILIA 39 0.0068
331 ECCHYMOSIS 47 0.0068
332 ILEUS 85 0.0068
333 HYPERNATRAEMIA 34 0.0068
334 LEUKAEMIA 64 0.0068
335 PULMONARY ALVEOLAR HAEMORRHAGE 38 0.0068
336 HEPATIC CYST 23 0.0068
337 ILEUS PARALYTIC 30 0.0067
338 SPINAL OSTEOARTHRITIS 59 0.0067
339 PATHOLOGICAL FRACTURE 34 0.0067
340 ASCITES 196 0.0067
341 COAGULOPATHY 111 0.0067
342 C-REACTIVE PROTEIN INCREASED 241 0.0066
343 HEPATIC CYTOLYSIS 84 0.0066
344 LUNG INFECTION 102 0.0066
345 FAILURE TO THRIVE 34 0.0065
346 LOW BIRTH WEIGHT BABY 52 0.0065
347 TONSILLITIS 34 0.0065
348 NEONATAL RESPIRATORY DISTRESS SYNDROME 23 0.0065
349 HYPERTRIGLYCERIDAEMIA 38 0.0065
350 PSYCHOLOGICAL TRAUMA 56 0.0065
351 LOCALISED OEDEMA 30 0.0065
352 NECROSIS 36 0.0065
353 HAEMORRHAGIC DIATHESIS 23 0.0065
354 BLOOD LACTIC ACID INCREASED 34 0.0064
355 HYPONATRAEMIA 362 0.0064
356 HERPES VIRUS INFECTION 37 0.0064
357 UROSEPSIS 59 0.0064
358 HEPATIC NECROSIS 24 0.0064
359 IMMUNE THROMBOCYTOPENIA 29 0.0063
360 HAEMOGLOBIN DECREASED 649 0.0063
361 HEPATOMEGALY 62 0.0063
362 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 147 0.0063
363 LEFT VENTRICULAR DYSFUNCTION 42 0.0063
364 MALNUTRITION 70 0.0063
365 ANAL ABSCESS 33 0.0061
366 GAMMA-GLUTAMYLTRANSFERASE INCREASED 135 0.0061
367 PURULENT DISCHARGE 26 0.0061
368 LYMPHOMA 94 0.0061
369 TRANSAMINASES INCREASED 135 0.0061
370 BLOOD ALBUMIN DECREASED 48 0.0060
371 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 47 0.0060
372 SMALL FOR DATES BABY 30 0.0060
373 HEPATIC LESION 26 0.0060
374 AZOTAEMIA 24 0.0060
375 GUILLAIN-BARRE SYNDROME 29 0.0060
376 FACE OEDEMA 101 0.0060
377 RESPIRATORY SYNCYTIAL VIRUS INFECTION 52 0.0060
378 PERIORBITAL OEDEMA 31 0.0060
379 PNEUMONIA 1923 0.0059
380 COLITIS ISCHAEMIC 40 0.0059
381 TOXIC ENCEPHALOPATHY 30 0.0059
382 METASTASES TO BONE 97 0.0059
383 IMMUNOSUPPRESSION 52 0.0059
384 NEOPLASM PROGRESSION 205 0.0059
385 MYELOSUPPRESSION 212 0.0059
386 ORAL INFECTION 23 0.0059
387 BRAIN OEDEMA 74 0.0059
388 HYPERGLYCAEMIA 213 0.0058
389 ANOREXIA 75 0.0058
390 FOETAL GROWTH RESTRICTION 35 0.0058
391 ALANINE AMINOTRANSFERASE INCREASED 351 0.0057
392 METASTASES TO LUNG 66 0.0057
393 HAEMOLYSIS 44 0.0057
394 THERAPY NON-RESPONDER 256 0.0057
395 HAEMOLYTIC ANAEMIA 51 0.0057
396 GASTROENTERITIS 83 0.0057
397 APHTHOUS ULCER 44 0.0057
398 PERICARDIAL EFFUSION 131 0.0057
399 METASTASES TO CENTRAL NERVOUS SYSTEM 73 0.0057
400 RECURRENT CANCER 23 0.0056
401 TUMOUR MARKER INCREASED 27 0.0056
402 DERMATITIS ACNEIFORM 34 0.0056
403 MATERNAL EXPOSURE BEFORE PREGNANCY 38 0.0056
404 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 28 0.0055
405 HAEMORRHAGE INTRACRANIAL 82 0.0055
406 ASPARTATE AMINOTRANSFERASE INCREASED 291 0.0055
407 UPPER RESPIRATORY TRACT INFECTION 253 0.0055
408 PHLEBITIS 28 0.0055
409 DEEP VEIN THROMBOSIS 355 0.0055
410 PURPURA 48 0.0054
411 ENCEPHALOPATHY 133 0.0054
412 RESPIRATORY TRACT INFECTION 141 0.0054
413 BREAST CANCER METASTATIC 58 0.0054
414 BLOOD UREA INCREASED 90 0.0054
415 SKIN INFECTION 60 0.0053
416 ACUTE PULMONARY OEDEMA 30 0.0053
417 BLOOD ALKALINE PHOSPHATASE INCREASED 132 0.0053
418 HYPOVOLAEMIA 31 0.0053
419 PROCTALGIA 34 0.0053
420 HEPATIC FAILURE 159 0.0053
421 BREATH SOUNDS ABNORMAL 26 0.0053
422 DERMATITIS BULLOUS 38 0.0052
423 PHARYNGITIS 65 0.0052
424 HYPERTHERMIA 40 0.0052
425 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
426 FULL BLOOD COUNT DECREASED 105 0.0052
427 LYMPHOEDEMA 36 0.0052
428 BLOOD URIC ACID INCREASED 30 0.0052
429 METASTASIS 37 0.0052
430 FLUID OVERLOAD 75 0.0051
431 LUNG NEOPLASM 22 0.0051
432 PERFORMANCE STATUS DECREASED 24 0.0051
433 CARDIOMYOPATHY 76 0.0051
434 SQUAMOUS CELL CARCINOMA OF SKIN 31 0.0051
435 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 49 0.0051
436 FLANK PAIN 47 0.0050
437 GENERALISED OEDEMA 62 0.0050
438 RESPIRATORY DISTRESS 138 0.0050
439 RALES 29 0.0050
440 NEPHROTIC SYNDROME 34 0.0050
441 SPINAL COMPRESSION FRACTURE 41 0.0050
442 INTERSTITIAL LUNG DISEASE 240 0.0050
443 PROTEINURIA 94 0.0049
444 HAEMODYNAMIC INSTABILITY 37 0.0049
445 ACIDOSIS 37 0.0048
446 CARDIAC TAMPONADE 23 0.0048
447 FAECAL INCONTINENCE 23 0.0048
448 ATRIAL FIBRILLATION 464 0.0048
449 PRODUCT STORAGE ERROR 417 0.0048
450 ATRIAL FLUTTER 38 0.0048
451 PYELONEPHRITIS 41 0.0047
452 PNEUMOTHORAX 75 0.0047
453 MITRAL VALVE INCOMPETENCE 53 0.0047
454 SQUAMOUS CELL CARCINOMA 44 0.0047
455 COMPRESSION FRACTURE 25 0.0047
456 ACUTE KIDNEY INJURY 712 0.0046
457 HAEMATURIA 159 0.0046
458 ANGIOPATHY 26 0.0046
459 INTESTINAL PERFORATION 52 0.0046
460 ABDOMINAL TENDERNESS 23 0.0046
461 HICCUPS 38 0.0046
462 MOUTH ULCERATION 97 0.0046
463 ORAL PAIN 103 0.0046
464 NON-SMALL CELL LUNG CANCER 22 0.0046
465 RENAL FAILURE ACUTE 194 0.0046
466 BLOOD CREATININE INCREASED 298 0.0046
467 DECUBITUS ULCER 37 0.0045
468 INTESTINAL ISCHAEMIA 25 0.0045
469 ABSCESS 72 0.0045
470 DISEASE RECURRENCE 214 0.0045
471 DIARRHOEA HAEMORRHAGIC 42 0.0045
472 BASAL CELL CARCINOMA 70 0.0045
473 PULMONARY FIBROSIS 86 0.0045
474 CHOLESTASIS 86 0.0045
475 RHINITIS 36 0.0045
476 HYPERVOLAEMIA 22 0.0044
477 REFUSAL OF TREATMENT BY PATIENT 29 0.0044
478 OSTEOMYELITIS 80 0.0044
479 CARDIOMEGALY 54 0.0044
480 SMALL INTESTINAL OBSTRUCTION 54 0.0044
481 SUPRAVENTRICULAR TACHYCARDIA 42 0.0044
482 EPISTAXIS 327 0.0044
483 TOXIC SKIN ERUPTION 44 0.0044
484 URINE OUTPUT DECREASED 38 0.0043
485 PREMATURE DELIVERY 69 0.0043
486 LOWER RESPIRATORY TRACT INFECTION 197 0.0043
487 MUSCULOSKELETAL CHEST PAIN 67 0.0043
488 HEPATITIS B 26 0.0043
489 HAEMODIALYSIS 36 0.0043
490 BONE DISORDER 78 0.0043
491 DRUG TOXICITY 58 0.0043
492 CARDIAC FAILURE 340 0.0042
493 CIRCULATORY COLLAPSE 72 0.0042
494 SKIN REACTION 59 0.0042
495 LARGE INTESTINE PERFORATION 29 0.0042
496 CYSTITIS 132 0.0041
497 HAIR DISORDER 34 0.0041
498 ACUTE CORONARY SYNDROME 34 0.0041
499 OVERWEIGHT 22 0.0041
500 ORAL DISORDER 30 0.0041
501 MOUTH HAEMORRHAGE 30 0.0041
502 OSTEONECROSIS OF JAW 101 0.0041
503 SKIN LESION 111 0.0040
504 MYOCARDIAL ISCHAEMIA 46 0.0040
505 RENAL CYST 32 0.0040
506 BLOOD POTASSIUM DECREASED 121 0.0040
507 BODY TEMPERATURE INCREASED 82 0.0040
508 MYOCARDITIS 46 0.0040
509 TACHYCARDIA 355 0.0040
510 CEREBRAL HAEMORRHAGE 143 0.0040
511 HYPOTENSION 801 0.0040
512 METABOLIC DISORDER 23 0.0040
513 CONJUNCTIVITIS 73 0.0039
514 PAIN IN JAW 111 0.0039
515 SUBDURAL HAEMATOMA 56 0.0039
516 MALIGNANT NEOPLASM PROGRESSION 399 0.0039
517 HAEMORRHOIDS 76 0.0039
518 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 40 0.0039
519 PULMONARY MASS 58 0.0039
520 OEDEMA 211 0.0039
521 DEHYDRATION 516 0.0039
522 RENAL FAILURE 511 0.0038
523 TACHYPNOEA 52 0.0038
524 PULMONARY OEDEMA 171 0.0038
525 RENAL FAILURE CHRONIC 29 0.0038
526 HYPERTRANSAMINASAEMIA 26 0.0037
527 HYPERCHLORHYDRIA 22 0.0037
528 STEVENS-JOHNSON SYNDROME 83 0.0037
529 PULMONARY EMBOLISM 352 0.0037
530 GENERAL PHYSICAL HEALTH DETERIORATION 428 0.0037
531 HYPERLIPIDAEMIA 44 0.0037
532 PROTHROMBIN TIME PROLONGED 22 0.0037
533 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
534 CHILLS 429 0.0037
535 LIPASE INCREASED 28 0.0037
536 OFF LABEL USE 3198 0.0036
537 BLOOD CALCIUM INCREASED 32 0.0036
538 BLOOD CALCIUM DECREASED 41 0.0036
539 BLOOD TEST ABNORMAL 51 0.0036
540 HEPATIC FUNCTION ABNORMAL 134 0.0036
541 PREMATURE BABY 108 0.0036
542 RESPIRATORY DISORDER 107 0.0036
543 INCORRECT PRODUCT STORAGE 47 0.0036
544 BLOOD COUNT ABNORMAL 54 0.0036
545 DIARRHOEA 2297 0.0036
546 CHOLANGITIS 22 0.0035
547 UNRESPONSIVE TO STIMULI 91 0.0035
548 SKIN ULCER 91 0.0035
549 OSTEOPENIA 53 0.0035
550 ISCHAEMIC STROKE 62 0.0035
551 LIVER DISORDER 153 0.0034
552 SHOCK HAEMORRHAGIC 28 0.0034
553 CONSTIPATION 748 0.0034
554 SPINAL PAIN 40 0.0034
555 RENAL IMPAIRMENT 286 0.0034
556 SUDDEN DEATH 36 0.0034
557 LOWER GASTROINTESTINAL HAEMORRHAGE 25 0.0034
558 RESPIRATORY RATE INCREASED 30 0.0034
559 HAIR COLOUR CHANGES 42 0.0034
560 GINGIVAL BLEEDING 46 0.0034
561 ABDOMINAL PAIN 782 0.0034
562 TOOTH ABSCESS 34 0.0033
563 HYPOTHYROIDISM 106 0.0033
564 APPENDICITIS 31 0.0033
565 JAUNDICE 89 0.0033
566 HAEMOPTYSIS 92 0.0033
567 ASPIRATION 36 0.0033
568 LABORATORY TEST ABNORMAL 97 0.0033
569 MENTAL STATUS CHANGES 91 0.0033
570 THROMBOSIS 263 0.0033
571 DECREASED APPETITE 757 0.0033
572 SYNCOPE 326 0.0033
573 WRONG DRUG ADMINISTERED 29 0.0033
574 BACK PAIN 755 0.0032
575 DIVERTICULUM 23 0.0032
576 HYPOPHAGIA 82 0.0032
577 EYELID OEDEMA 37 0.0032
578 OEDEMA PERIPHERAL 387 0.0032
579 PULMONARY HYPERTENSION 66 0.0032
580 HEPATIC STEATOSIS 59 0.0032
581 VOMITING 1488 0.0032
582 RENAL TUBULAR NECROSIS 31 0.0032
583 MUSCLE ATROPHY 40 0.0032
584 TROPONIN INCREASED 24 0.0032
585 VENTRICULAR FIBRILLATION 35 0.0031
586 HERPES ZOSTER 181 0.0031
587 HEPATIC ENCEPHALOPATHY 29 0.0031
588 WOUND INFECTION 34 0.0031
589 PRODUCTIVE COUGH 148 0.0031
590 EAR PAIN 60 0.0031
591 HYPERKALAEMIA 108 0.0031
592 TENDERNESS 32 0.0031
593 MADAROSIS 35 0.0030
594 PRESYNCOPE 73 0.0030
595 GASTRITIS 79 0.0030
596 DEVICE PHYSICAL PROPERTY ISSUE 23 0.0030
597 EOSINOPHIL COUNT INCREASED 25 0.0030
598 MELAENA 66 0.0030
599 HAEMATEMESIS 76 0.0030
600 PLATELET COUNT INCREASED 39 0.0030
601 LETHARGY 172 0.0030
602 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 87 0.0030
603 IMMUNE SYSTEM DISORDER 39 0.0030
604 SHOCK 68 0.0030
605 PELVIC FRACTURE 23 0.0030
606 GASTROINTESTINAL INFLAMMATION 23 0.0029
607 IRON DEFICIENCY ANAEMIA 27 0.0029
608 LUNG DISORDER 143 0.0029
609 PERICARDITIS 49 0.0029
610 GASTROINTESTINAL INFECTION 26 0.0029
611 ERYTHEMA MULTIFORME 27 0.0029
612 DENTAL CARIES 32 0.0029
613 VENTRICULAR EXTRASYSTOLES 30 0.0029
614 ASTHENIA 1083 0.0029
615 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 158 0.0029
616 SKIN FISSURES 56 0.0029
617 CHOLECYSTITIS 34 0.0029
618 EXOSTOSIS 26 0.0028
619 SUBARACHNOID HAEMORRHAGE 29 0.0028
620 URINARY TRACT INFECTION 485 0.0028
621 HAIR TEXTURE ABNORMAL 38 0.0028
622 HEPATOCELLULAR INJURY 40 0.0028
623 DERMATITIS 59 0.0028
624 METABOLIC ACIDOSIS 90 0.0028
625 ADRENAL INSUFFICIENCY 34 0.0028
626 FURUNCLE 22 0.0028
627 NIGHT SWEATS 89 0.0028
628 ORTHOSTATIC HYPOTENSION 48 0.0028
629 DECREASED IMMUNE RESPONSIVENESS 27 0.0027
630 IMMUNODEFICIENCY 41 0.0027
631 CAESAREAN SECTION 32 0.0027
632 NAIL DISORDER 24 0.0027
633 EOSINOPHILIA 48 0.0027
634 UPPER GASTROINTESTINAL HAEMORRHAGE 46 0.0027
635 MUSCLE TWITCHING 63 0.0027
636 ALOPECIA 531 0.0027
637 PERITONITIS 56 0.0027
638 GASTROINTESTINAL DISORDER 242 0.0027
639 HYPERTHYROIDISM 39 0.0027
640 GASTRIC ULCER 51 0.0027
641 LIVER FUNCTION TEST ABNORMAL 78 0.0027
642 FOLLICULITIS 28 0.0027
643 ARTERIOSCLEROSIS 25 0.0027
644 DEATH 2288 0.0027
645 BLOOD SODIUM DECREASED 50 0.0026
646 TOOTH EXTRACTION 33 0.0026
647 CARDIOGENIC SHOCK 38 0.0026
648 NOCTURIA 32 0.0026
649 NEURALGIA 64 0.0026
650 NAUSEA 2067 0.0026
651 URINARY RETENTION 87 0.0026
652 COUGH 724 0.0026
653 FISTULA 29 0.0026
654 FEEDING DISORDER 52 0.0026
655 CARDIAC ARREST 211 0.0026
656 HIATUS HERNIA 33 0.0025
657 DELIRIUM 88 0.0025
658 INFUSION RELATED REACTION 167 0.0025
659 APHASIA 76 0.0025
660 ULCER 40 0.0025
661 RECTAL HAEMORRHAGE 108 0.0025
662 GASTROINTESTINAL HAEMORRHAGE 210 0.0025
663 DYSURIA 92 0.0025
664 DRUG ERUPTION 44 0.0025
665 UNEVALUABLE EVENT 187 0.0025
666 OXYGEN SATURATION DECREASED 138 0.0025
667 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 42 0.0024
668 MUSCULOSKELETAL PAIN 128 0.0024
669 DYSPNOEA EXERTIONAL 92 0.0024
670 PNEUMONIA ASPIRATION 61 0.0024
671 PRODUCT USE IN UNAPPROVED INDICATION 603 0.0024
672 MASS 34 0.0024
673 TOOTH INFECTION 32 0.0024
674 ACUTE HEPATIC FAILURE 33 0.0024
675 PATHOGEN RESISTANCE 22 0.0024
676 FATIGUE 1864 0.0024
677 BRAIN INJURY 24 0.0024
678 ARRHYTHMIA 113 0.0024
679 RENAL PAIN 25 0.0024
680 SARS-COV-2 TEST POSITIVE 31 0.0023
681 HEPATITIS 60 0.0023
682 DRUG RESISTANCE 60 0.0023
683 CHEST PAIN 429 0.0023
684 ACUTE MYOCARDIAL INFARCTION 68 0.0023
685 CARDIO-RESPIRATORY ARREST 96 0.0023
686 IMPAIRED HEALING 75 0.0023
687 PULMONARY CONGESTION 30 0.0023
688 PANCREATITIS ACUTE 51 0.0023
689 PELVIC PAIN 41 0.0023
690 LOWER LIMB FRACTURE 43 0.0022
691 NEEDLE ISSUE 65 0.0022
692 WEIGHT DECREASED 621 0.0022
693 RASH ERYTHEMATOUS 106 0.0022
694 DYSPNOEA 1255 0.0022
695 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 57 0.0022
696 HYPOTONIA 22 0.0022
697 DIVERTICULITIS 61 0.0022
698 VENTRICULAR TACHYCARDIA 36 0.0022
699 LOCAL SWELLING 38 0.0022
700 FULL BLOOD COUNT ABNORMAL 23 0.0022
701 MYALGIA 369 0.0022
702 SKIN DISORDER 72 0.0022
703 BREAST PAIN 23 0.0022
704 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 153 0.0021
705 INTERVERTEBRAL DISC PROTRUSION 47 0.0021
706 DYSPHAGIA 204 0.0021
707 DERMATITIS ALLERGIC 27 0.0021
708 RIB FRACTURE 44 0.0021
709 INFLUENZA LIKE ILLNESS 174 0.0021
710 TOOTH DISORDER 47 0.0021
711 NECK PAIN 118 0.0021
712 HAEMORRHAGE 219 0.0021
713 RHINORRHOEA 135 0.0021
714 RASH 899 0.0021
715 ABDOMINAL DISTENSION 214 0.0020
716 HAEMATOMA 53 0.0020
717 COVID-19 358 0.0020
718 OSTEONECROSIS 67 0.0020
719 INFLAMMATION 105 0.0020
720 ELECTROCARDIOGRAM QT PROLONGED 73 0.0020
721 MALIGNANT MELANOMA 27 0.0020
722 NEOPLASM 23 0.0020
723 PALLOR 54 0.0020
724 HYPERTENSIVE CRISIS 22 0.0020
725 OROPHARYNGEAL PAIN 183 0.0020
726 RASH PRURITIC 107 0.0020
727 TASTE DISORDER 40 0.0020
728 RESTLESSNESS 72 0.0020
729 THERAPEUTIC RESPONSE DECREASED 119 0.0020
730 HEMIPARESIS 33 0.0019
731 SYRINGE ISSUE 34 0.0019
732 BLOOD PRESSURE DECREASED 129 0.0019
733 CONFUSIONAL STATE 313 0.0019
734 NERVOUS SYSTEM DISORDER 60 0.0019
735 MATERNAL EXPOSURE DURING PREGNANCY 170 0.0019
736 PERIPHERAL COLDNESS 26 0.0019
737 NEOPLASM MALIGNANT 126 0.0019
738 BRONCHITIS 139 0.0019
739 SWELLING FACE 122 0.0019
740 LIVER FUNCTION TEST INCREASED 40 0.0019
741 INTESTINAL OBSTRUCTION 70 0.0019
742 ATAXIA 22 0.0019
743 DEPRESSED LEVEL OF CONSCIOUSNESS 73 0.0018
744 HEPATIC ENZYME INCREASED 125 0.0018
745 DRUG INTOLERANCE 177 0.0018
746 DIALYSIS 26 0.0018
747 CARDIAC FAILURE CONGESTIVE 147 0.0018
748 CHOLELITHIASIS 60 0.0018
749 HEPATITIS C 22 0.0018
750 INTENTIONAL PRODUCT USE ISSUE 159 0.0018
751 RASH GENERALISED 47 0.0018
752 ADVERSE EVENT 167 0.0018
753 DYSGEUSIA 134 0.0018
754 CONVULSION 103 0.0018
755 SPINAL FRACTURE 36 0.0018
756 CYANOSIS 28 0.0018
757 DYSPEPSIA 175 0.0018
758 HYPOAESTHESIA 266 0.0018
759 OSTEOARTHRITIS 75 0.0018
760 TOOTHACHE 32 0.0018
761 HOSPITALISATION 271 0.0018
762 NODULE 23 0.0018
763 HEPATIC CIRRHOSIS 33 0.0018
764 BRONCHOSPASM 25 0.0018
765 HYPERTENSION 371 0.0017
766 BLISTER 98 0.0017
767 COLON CANCER 26 0.0017
768 ABDOMINAL PAIN LOWER 44 0.0017
769 RASH PAPULAR 39 0.0017
770 EPILEPSY 53 0.0017
771 ALTERED STATE OF CONSCIOUSNESS 37 0.0017
772 SINUSITIS 174 0.0017
773 PHOTOSENSITIVITY REACTION 28 0.0017
774 URINARY INCONTINENCE 50 0.0017
775 DEVICE OCCLUSION 23 0.0016
776 BLOOD CREATINE PHOSPHOKINASE INCREASED 46 0.0016
777 INFLUENZA 178 0.0016
778 PARAESTHESIA 251 0.0016
779 CHROMATURIA 36 0.0016
780 ERYTHEMA 327 0.0016
781 RENAL DISORDER 74 0.0016
782 SEIZURE 182 0.0016
783 MUSCULAR WEAKNESS 178 0.0016
784 TOXICITY TO VARIOUS AGENTS 264 0.0016
785 POLLAKIURIA 65 0.0016
786 CEREBRAL INFARCTION 38 0.0016
787 TUBULOINTERSTITIAL NEPHRITIS 29 0.0015
788 FEELING COLD 43 0.0015
789 TRANSIENT ISCHAEMIC ATTACK 52 0.0015
790 WOUND 43 0.0015
791 TREATMENT FAILURE 127 0.0015
792 CONTUSION 147 0.0015
793 INJECTION SITE HAEMATOMA 22 0.0015
794 GOUT 27 0.0015
795 EATING DISORDER 32 0.0015
796 CONDITION AGGRAVATED 454 0.0015
797 DEAFNESS 39 0.0015
798 ECZEMA 78 0.0015
799 PAIN IN EXTREMITY 436 0.0015
800 ARTHRALGIA 610 0.0015
801 HYPERSENSITIVITY 271 0.0015
802 OSTEOPOROSIS 60 0.0015
803 CORONARY ARTERY DISEASE 44 0.0015
804 RESPIRATORY ARREST 40 0.0014
805 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
806 ANAPHYLACTIC REACTION 80 0.0014
807 DISORIENTATION 57 0.0014
808 SENSORY DISTURBANCE 23 0.0014
809 LACRIMATION INCREASED 43 0.0014
810 LOSS OF CONSCIOUSNESS 182 0.0014
811 PRODUCT USE ISSUE 266 0.0014
812 MALAISE 618 0.0014
813 ILL-DEFINED DISORDER 85 0.0014
814 ANAPHYLACTIC SHOCK 36 0.0014
815 DIPLOPIA 36 0.0014
816 PAIN 841 0.0014
817 ABDOMINAL PAIN UPPER 281 0.0014
818 PANCREATITIS 72 0.0014
819 PALPITATIONS 159 0.0014
820 CHEST DISCOMFORT 139 0.0014
821 BLOOD POTASSIUM INCREASED 22 0.0014
822 POST PROCEDURAL COMPLICATION 26 0.0014
823 DYSPHONIA 79 0.0013
824 HYPOGLYCAEMIA 65 0.0013
825 BRADYCARDIA 71 0.0013
826 MUSCULOSKELETAL DISCOMFORT 23 0.0013
827 ANHEDONIA 35 0.0013
828 SKIN EXFOLIATION 112 0.0013
829 LOCALISED INFECTION 32 0.0013
830 EAR INFECTION 35 0.0013
831 INSOMNIA 350 0.0013
832 COLD SWEAT 23 0.0013
833 HYPERHIDROSIS 168 0.0013
834 GASTROOESOPHAGEAL REFLUX DISEASE 104 0.0013
835 LUNG NEOPLASM MALIGNANT 53 0.0013
836 ARTHRITIS 101 0.0013
837 GASTROENTERITIS VIRAL 23 0.0013
838 HAEMATOCHEZIA 70 0.0013
839 BLOOD URINE PRESENT 24 0.0013
840 LIMB DISCOMFORT 39 0.0013
841 TOOTH LOSS 26 0.0013
842 DRUG INTERACTION 198 0.0012
843 DRUG-INDUCED LIVER INJURY 39 0.0012
844 HEART RATE INCREASED 122 0.0012
845 FOETAL EXPOSURE DURING PREGNANCY 100 0.0012
846 INTERNATIONAL NORMALISED RATIO INCREASED 35 0.0012
847 EXPOSURE DURING PREGNANCY 76 0.0012
848 LIVER INJURY 30 0.0012
849 ANGIOEDEMA 54 0.0012
850 JOINT STIFFNESS 32 0.0012
851 CATARACT 72 0.0012
852 MUSCULOSKELETAL DISORDER 23 0.0012
853 FLUID RETENTION 61 0.0012
854 PERIPHERAL SWELLING 183 0.0012
855 DRY MOUTH 95 0.0012
856 HEADACHE 734 0.0012
857 VERTIGO 71 0.0012
858 COGNITIVE DISORDER 54 0.0012
859 PREGNANCY 23 0.0011
860 CARDIOVASCULAR DISORDER 29 0.0011
861 MUSCLE SPASMS 209 0.0011
862 HALLUCINATION, VISUAL 24 0.0011
863 WHEEZING 67 0.0011
864 NASOPHARYNGITIS 207 0.0011
865 AGEUSIA 28 0.0011
866 HIP FRACTURE 36 0.0011
867 PSYCHOTIC DISORDER 33 0.0011
868 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 58 0.0011
869 SKIN DISCOLOURATION 51 0.0011
870 FAECES DISCOLOURED 24 0.0011
871 HEART RATE IRREGULAR 25 0.0011
872 DIZZINESS 546 0.0011
873 CARDIAC DISORDER 102 0.0011
874 NEPHROLITHIASIS 50 0.0011
875 RASH MACULAR 38 0.0011
876 LACTIC ACIDOSIS 35 0.0011
877 RETCHING 23 0.0011
878 PRURITUS 414 0.0011
879 FLATULENCE 61 0.0011
880 VISUAL ACUITY REDUCED 35 0.0011
881 DYSARTHRIA 39 0.0010
882 TINNITUS 47 0.0010
883 ADVERSE DRUG REACTION 91 0.0010
884 BREAST CANCER 94 0.0010
885 COMA 48 0.0010
886 SWELLING 94 0.0010
887 DISCOMFORT 61 0.0010
888 ABORTION SPONTANEOUS 40 0.0010
889 WEIGHT INCREASED 223 0.0010
890 DYSSTASIA 29 0.0010
891 DRUG EFFECT INCOMPLETE 36 0.0010
892 TREMOR 164 0.0010
893 FALL 327 0.0010
894 HALLUCINATION 74 0.0010
895 THROAT IRRITATION 44 0.0010
896 DRY SKIN 130 0.0010
897 EYE SWELLING 36 0.0010
898 VAGINAL HAEMORRHAGE 42 0.0010
899 DEVICE ISSUE 85 0.0009
900 DEPRESSION 212 0.0009
901 ABASIA 23 0.0009
902 FEELING HOT 57 0.0009
903 DISTURBANCE IN ATTENTION 49 0.0009
904 ANGINA PECTORIS 26 0.0009
905 HYPOACUSIS 39 0.0009
906 DRUG INEFFECTIVE 1184 0.0009
907 SWOLLEN TONGUE 28 0.0009
908 URTICARIA 150 0.0009
909 MOBILITY DECREASED 64 0.0009
910 ABDOMINAL DISCOMFORT 147 0.0009
911 ANXIETY 249 0.0009
912 MENTAL DISORDER 38 0.0009
913 FLUSHING 88 0.0009
914 VISUAL IMPAIRMENT 106 0.0009
915 DIABETES MELLITUS 65 0.0009
916 FREQUENT BOWEL MOVEMENTS 23 0.0009
917 HOT FLUSH 64 0.0008
918 DRUG ADMINISTRATION ERROR 26 0.0008
919 VISION BLURRED 115 0.0008
920 AMNESIA 54 0.0008
921 MEDICATION ERROR 46 0.0008
922 BLOOD PRESSURE INCREASED 126 0.0008
923 BLINDNESS 33 0.0008
924 ARTHROPATHY 45 0.0008
925 HYPERSOMNIA 23 0.0008
926 RHABDOMYOLYSIS 33 0.0008
927 AGITATION 58 0.0008
928 JOINT SWELLING 95 0.0008
929 INCORRECT ROUTE OF DRUG ADMINISTRATION 28 0.0008
930 RENAL INJURY 23 0.0008
931 GAIT DISTURBANCE 147 0.0008
932 DRUG EXPOSURE DURING PREGNANCY 26 0.0008
933 INJURY 53 0.0008
934 LIP SWELLING 25 0.0007
935 CEREBROVASCULAR ACCIDENT 123 0.0007
936 GAIT INABILITY 24 0.0007
937 IRRITABILITY 43 0.0007
938 BURNING SENSATION 50 0.0007
939 TREATMENT NONCOMPLIANCE 39 0.0007
940 NASAL CONGESTION 41 0.0007
941 HEAD INJURY 22 0.0007
942 SPEECH DISORDER 36 0.0007
943 UNDERDOSE 50 0.0007
944 HEART RATE DECREASED 24 0.0007
945 BALANCE DISORDER 59 0.0007
946 MYOCARDIAL INFARCTION 119 0.0007
947 AGGRESSION 34 0.0007
948 SYSTEMIC LUPUS ERYTHEMATOSUS 24 0.0007
949 DRY EYE 33 0.0007
950 CHRONIC KIDNEY DISEASE 50 0.0007
951 ACCIDENTAL OVERDOSE 24 0.0007
952 MEMORY IMPAIRMENT 89 0.0006
953 FEELING ABNORMAL 153 0.0006
954 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 45 0.0006
955 SLEEP DISORDER 44 0.0006
956 DRUG DOSE OMISSION 102 0.0006
957 SOMNOLENCE 121 0.0006
958 INTENTIONAL PRODUCT MISUSE 52 0.0006
959 NERVOUSNESS 31 0.0006
960 MIGRAINE 56 0.0006
961 INJECTION SITE PAIN 172 0.0006
962 DEPRESSED MOOD 29 0.0005
963 THERAPY CESSATION 28 0.0005
964 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 109 0.0005
965 MUSCULOSKELETAL STIFFNESS 47 0.0005
966 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
967 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 93 0.0005
968 BLOOD GLUCOSE INCREASED 94 0.0005
969 SURGERY 29 0.0005
970 DRUG EFFECT DECREASED 26 0.0005
971 EMOTIONAL DISTRESS 58 0.0005
972 OVERDOSE 103 0.0005
973 PROSTATE CANCER 37 0.0005
974 INJECTION SITE REACTION 31 0.0005
975 THERAPY INTERRUPTED 32 0.0004
976 INJECTION SITE ERYTHEMA 55 0.0004
977 ASTHMA 48 0.0004
978 BLADDER CANCER 24 0.0004
979 DRUG DOSE OMISSION BY DEVICE 31 0.0004
980 ACCIDENTAL EXPOSURE TO PRODUCT 40 0.0004
981 INJECTION SITE BRUISING 30 0.0004
982 NO ADVERSE EVENT 67 0.0004
983 ILLNESS 38 0.0004
984 PRODUCT DOSE OMISSION 24 0.0004
985 ACNE 27 0.0004
986 MULTIPLE SCLEROSIS RELAPSE 23 0.0003
987 INJECTION SITE HAEMORRHAGE 23 0.0003
988 INCORRECT DOSE ADMINISTERED 65 0.0003
989 RHEUMATOID ARTHRITIS 29 0.0003
990 PSORIASIS 33 0.0003
991 PRODUCT DOSE OMISSION ISSUE 74 0.0003
992 PRODUCT QUALITY ISSUE 25 0.0002